Richard A. Sandberg Sells 2,000 Shares of Precipio, Inc. (NASDAQ:PRPO) Stock

Precipio, Inc. (NASDAQ:PRPO) Director Richard A. Sandberg sold 2,000 shares of the stock in a transaction that occurred on Monday, November 11th. The shares were sold at an average price of $6.28, for a total transaction of $12,560.00. Following the completion of the sale, the director now directly owns 16,525 shares of the company’s stock, valued at $103,777. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Precipio Price Performance

Shares of PRPO stock opened at $6.35 on Thursday. Precipio, Inc. has a twelve month low of $4.31 and a twelve month high of $8.49. The company has a market capitalization of $9.40 million, a PE ratio of -3.47 and a beta of 1.42. The company has a current ratio of 0.73, a quick ratio of 0.60 and a debt-to-equity ratio of 0.02. The firm has a fifty day simple moving average of $6.47 and a 200-day simple moving average of $5.90.

Precipio (NASDAQ:PRPO) last announced its earnings results on Tuesday, August 13th. The biotechnology company reported ($0.83) earnings per share (EPS) for the quarter. The business had revenue of $4.44 million for the quarter. Precipio had a negative return on equity of 34.01% and a negative net margin of 17.23%.

Precipio Company Profile

Precipio, Inc, a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels.